A major breakthrough in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in several kinds of malignancies, https://socialioapp.com/story6836022/nanobodies-reactivate-p53-a-potential-approach-for-tumor-management